Redondo-Sánchez, Daniel
Fernández-Navarro, Pablo
Rodríguez-Barranco, Miguel
Nuñez, Olivier
Petrova, Dafina
García-Torrecillas, Juan Manuel
Jiménez-Moleón, Jose Juan
Sánchez, María-José
Funding for this research was provided by:
High Resolution Study of Social Inequalities in Cancer (HiReSIC), Asociación Española Contra el Cáncer (PROYE20023SÁNC, PROYE20023SÁNC, PROYE20023SÁNC, PROYE20023SÁNC, PROYE20023SÁNC, PROYE20023SÁNC, PROYE20023SÁNC)
Subprograma de Vigilancia Epidemiológica del Cáncer (VICA), del CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable)
Instituto de Salud Carlos III (PI18/01593 EU/FEDER, PI18/01593 EU/FEDER, PI18/01593 EU/FEDER)
Acciones de Movilidad CIBERESP, 2022 (Not applicable)
Juan de la Cierva Fellowship from the Ministry of Science and the National Research Agency of Spain (JC2019-039691-I)
Article History
Received: 7 May 2023
Accepted: 19 July 2023
First Online: 2 August 2023
Declarations
:
: The study protocol has received approval from the Internal Review Board of the Andalusian School of Public Health (CP17/00206), the Granada Provincial Research Review Committee, and the Biomedical Ethics Committee of the Department of Health of the Andalusian Regional Government (study 0072-N-18). The research is in accordance with the principles embodied in the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
: This article presents an independent research. The views expressed are those of the authors, and not necessarily those of the Carlos III Institute of Health.